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Abstract
Background—Bipolar disorder co-occurs with a number of disorders with externalizing 
features. The aim of this study is to determine whether Bipolar I (BPI) subjects with comorbid 
externalizing disorders and a subgroup with externalizing symptoms prior to age 15 have different 
clinical features than those without externalizing disorders and whether these could be attributed 
to specific genetic variations.
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Methods—A large cohort (N=2505) of Bipolar I subjects was analyzed. Course of illness 
parameters were compared between an Externalizing Group, an Early-Onset Subgroup and a Non-
Externalizing group in the Discovery sample (N=1268). Findings were validated using an 
independent set of 1237 BPI subjects (Validation sample). Genetic analyses were carried out.
Results—Subjects in the Externalizing Group (and Early-Onset Subgroup) tended to have a 
more severe clinical course, even in areas specifically related to mood disorder such as cycling 
frequency and rapid mood switching. Regression analysis showed that the differences are not 
completely explainable by substance use. Genetic analyses identified nominally associated SNPs; 
calcium channel genes were not enriched in the gene variants identified.
Limitations—Validation in independent samples is needed to confirm the genetic findings in the 
present study.
Conclusions—Our findings support the presence of an externalizing disorder subphenotype 
within BPI with greater severity of mood disorder and possible specific genetic features.
Keywords
Bipolar disorder; Externalizing disorders; Early onset; Comorbidity; Genome-wide association 
study (GWAS)
1. Introduction
Bipolar disorder (BP) includes distinct episodes with altered mood, activity, and thought 
patterns. The mean age at onset for Bipolar Disorder Type I (BPI) is 18.4 years and the 
lifetime prevalence is 0.6% (Merikangas et al., 2011). BP may occur in conjunction with a 
number of other disorders such as substance use and anxiety disorders (Merikangas et al., 
2011). Substance use has been shown to be highly prevalent in BP patients (Merikangas et 
al., 2011; Regier et al., 1990). Prior studies have identified more severe outcomes among BP 
patients with co-occurring substance use disorders (Cardoso et al., 2008; Elizabeth Sublette 
et al., 2009; Frye and Salloum, 2006; Grunebaum et al., 2006). The presence of substance 
abuse also makes it more difficult to treat BP (Swann, 2010). The disorder has a substantial 
genetic component. Monozygotic twin concordance rates range from 45 to 70% and sibling 
recurrence risk ranges from 5 to 10% (Craddock and Forty, 2006). Genome Wide 
Association Studies (GWAS) have identified ten common variants with modest effects 
(Chen et al., 2013; Ferreira et al., 2008; Seifuddin et al., 2012; Sklar, 2013; Sklar et al., 
2011; Smith et al., 2009; Smith et al., 2011), and analyses using the entire set of variants 
tested with common GWAS platforms suggest that many additional vulnerability genes 
remain to be identified as larger samples become available (Cross-Disorder Group of the 
Psychiatric Genomics et al., 2013; Lee et al., 2011). Many course of illness parameters have 
also been shown to be heritable (Potash et al., 2007). The aim of this study is to determine 
whether a subphenotype of BPI subjects can be defined based on the presence of 
externalizing disorders, and whether these subjects are clinically and/or genetically different 
from those who did not have externalizing disorders. We were particularly interested in 
whether the characteristics of the mood disorder itself (apart from externalizing symptoms) 
differentiated the subgroups. Two sets of BPI subjects ascertained by the National Institute 
of Mental Health (NIMH) Bipolar Disorder Genetics Initiative and evaluated with the 
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Diagnostic Instrument for Genetic Studies (Nurnberger et al., 1994) were included (a 
Discovery sample and a Validation sample). We also performed GWAS analyses using the 
combined sample to identify genetic variations that may help characterize these groups.
2. Methods
2.1. Clinical parameters
BPI subjects were selected from those collected and characterized by the National Institute 
of Mental Health (NIMH) Bipolar Disorder Genetics Initiative over the past 18 years. 
Subjects were from Indiana University, Johns Hopkins University, the National Institute of 
Mental Health Intramural (NIMH) Program, Washington University at St. Louis, University 
of Pennsylvania, University of California at San Diego, University of California at Irvine, 
University of California at San Francisco, University of Iowa, University of Chicago, Rush 
University, and Howard University.
The study protocol was approved by the Institutional Review Board of the respective 
universities. After description of the study to the subjects, written informed consent was 
obtained.
2.1.1. Discovery sample—Subjects totaled 951 unrelated European American (EA) 
individuals and 317 unrelated African-American (AA) individuals. EA status was 
determined based on the subject’s self-report that all four grandparents were of EA heritage. 
AA status was based on self-report of at least one grandparent being of AA heritage. The 
1268 BPI subjects were divided into the following groups: 1) the Non-Externalizing 
Group-472 subjects; 2) the Externalizing Group-796 subjects who had at least one 
externalizing disorder and 3) the Early-Onset Subgroup-329 subjects in the Externalizing 
Group who had two or more symptoms of conduct disorder (CD) prior to age 15 (Table 1). 
Externalizing disorders included one or more of the following DSM-IV diagnoses: alcohol 
abuse/dependence, drug abuse/dependence, pathological gambling, anti-social personality 
disorder (ASPD), attention-deficit hyperactivity disorder (ADHD) and CD (Table 2). Of 
note, about 70% of subjects in this sample came from multiplex families (additional affected 
relatives with BPI disorder).
2.1.2. Validation sample—The validation sample consisted of 1237 unrelated EA BPI 
subjects from the same study. Based on the above mentioned criteria, these subjects were 
also divided into 1) the Non-Externalizing Group-436 subjects; 2) the Externalizing 
Group-801 subjects and 3) the early-onset sub-group-307 subjects (Table 1). Of note, about 
20% of subjects in this sample came from multiplex families.
2.1.3. Clinical assessment—All subjects were interviewed with the Diagnostic 
Interview for Genetic Studies (DIGS) (Nurnberger et al., 1994), a diagnostic instrument 
developed for determining mood disorders and related conditions and shown to have 
excellent test-retest reliability. Final diagnoses were made by two independent clinicians 
incorporating all available information using a best-estimate procedure.
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2.2. Genome-wide association analyses
2.2.1. Genotyping and quality control of data available on dbGaP—Genotyping 
was carried out at the The Broad Institute Center for Genotyping and Analysis. PicoGreen 
fluorometry was used to check DNA quantity, and sample quality was initially assessed by 
genotyping a 24-single nucleotide polymorphism (SNP) panel on the Sequenom iPLEX 
platform containing a sex determining assay. Samples were plated at 50ng/ul in 96 well 
plates at the Rutgers University Cell and DNA Repository. The Centre d’Etude du 
Polymorphisme Human (CEPH; http://www.cephb.fr/en/cephdb/) sample NA12144 was 
placed on each production plate at the Broad Institute. Genotyping was carried out 
separately for the EA and AA samples using the Affymetrix Genome-Wide Human SNP 
Array 6.0. Allele calling was performed using the BirdSeed algorithm Affymetrix Power 
Tools version apt-1.8.6 and cluster models (‘priors’) file. Concordance between genotypes 
from the array and those from the initial quality control (QC) panel was evaluated to confirm 
sample ID. BPI EA Discovery and Validation samples were pooled together for the GWAS.
Samples were not used in the analysis if they had a low call rate (<98.5%) or incompatibility 
between reported gender and genetically determined gender. Pairwise identity-by-descent 
estimation was used to check for unexpected familial relationships in PLINK v1.07 (Purcell 
et al., 2007). SNPs were not analyzed if the minor allele frequency was <0.01, call rate 
<95%, Hardy Weinberg Equilibrium was violated (P<10−6) in control samples, if there were 
three or more Mendelian errors, or if there was more than one discrepancy among duplicate 
samples. 2064 samples and 677,171 SNPs passed all QC tests. Further information on QC 
can be obtained in (Smith et al., 2009; Smith et al., 2011).
2.3. Statistical analyses
2.3.1. Clinical parameter analyses—Statistical analyses were performed between the 
Non-Externalizing Group and the Externalizing Group of BPI subjects (including both early-
onset and later-onset subjects), and between the Non-Externalizing Group and the Early-
Onset Subgroup. Categorical variables were analyzed using the Pearson chi-square test 
(two-sided) and continuous variables were analyzed using an independent samples t-test 
(two-sided). Levene’s Test for Equality of Variances was performed to check the equality of 
variances assumption. All statistical analyses were performed in SPSS Statistics.
2.3.2. Genetic analyses—All genetic analyses were conducted using PLINK v1.07. The 
analyses involved testing the association of each SNP coded additively with externalizing 
and early-onset status, with subject sex included as a covariate in the logistic model 
employed.
3. Results
3.1. Subject distribution in the non-externalizing and Externalizing Groups
1268 BPI subjects (951 EA, 317 AA) were included in the Discovery phase of the analysis 
and the findings were validated using 1237 BPI subjects in the Validation sample (Table 1). 
The distribution of BPI subjects among the non-externalizing and Externalizing Groups, and 
the Early-Onset Subgroup was similar for the two samples.
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3.2. Prevalence of externalizing disorders
We then examined the distribution of externalizing disorders in the Externalizing Group of 
BPI subjects in the two studies (Table 2). A majority of subjects had alcohol abuse/
dependence and/or drug abuse/dependence. A higher proportion (P<0.05) of Discovery 
subjects had drug abuse/dependence and ASPD compared to Validation sample subjects. 
Conversely, a higher proportion (P<0.05) of Validation sample subjects had ADHD 
compared to Discovery subjects, but this may be related to assessment methodology (see 
Discussion). Further information on the breakdown of substance use disorders in the sample 
cohort can be found in Table S1.
3.3. Clinical characteristics
A number of clinical parameters were found to be significantly (P<0.05) different when 
comparing the Externalizing Group to the Non-Externalizing Group of BPI subjects in the 
Discovery sample (Tables 3 and 4). Subjects in the Externalizing Group were more likely to 
be male (χ2=9.012, df=1, P=0.003), to be disabled (χ2=6.932, df=1, P=0.008) and to have 
fewer years of schooling (t=6.694, df=1217, P<0.001). They had an earlier age at onset of 
BPI (t=7.250, df=776.393, P<0.001) (including earlier onset ages for both depression 
(t=5.533, df=796.274, P<0.001) and mania (t=5.807, df=837.128, P<0.001)), a higher 
number of depressive (χ2=20.902, df=1, P<0.001) and manic episodes (χ2=12.613, df=1, 
P<0.001, excluding episodes judged to be secondary to substance use) and a higher 
frequency of episodes (χ2=9.763, df=1, P=0.002; χ2=4.179, df=1, P=0.041). The subjects in 
the Externalizing Group had an increased frequency of incidents of (non-suicidal) self-harm 
(χ2=25.797, df=1, P<0.001) and more suicide attempts (t=−2.680, df=478.609, P=0.008). 
They were rated as more impaired on the interepisode Global Assessment Scale (GAS) 
(t=3.771, df=474, P<0.001) and were more likely to report a history of rapid switching 
(χ2=21.696, df=1, P<0.001) and rapid cycling (χ2=25.516, df=1, P<0.001). We have 
investigated the effect of ethnicity in externalizing disorders and we find similar results for 
EA and AA except for disability, frequency of depressive episodes, number and frequency 
of manic episodes, and age of first tobacco use in case of AA (Tables S2, S3, S4 and S5). 
The findings in BPI subjects in the overall Discovery sample (Tables 3 and 4) were 
replicated in BPI subjects in the Validation sample (Tables S6 and S7).
Examination of the clinical variables in the Early-Onset Subgroup shows the same pattern as 
in the Externalizing Group as a whole, but in general the differences are greater. Non-
suicidal self-harm was seen in 30.2% of early-onset subjects as compared to 10.0% of non-
externalizing subjects (and 26.0% of externalizing subjects as a whole). Rapid switching 
was seen in 70.6% of early-onset subjects as compared to 48.6% of non-externalizing 
subjects (and 62.8% of externalizing subjects). Although they are younger, 56.7% of early-
onset externalizing subjects have had >8 non-substance-related depressive episodes in their 
lifetime compared with 35.5% of non-externalizing subjects (and 49.5% of externalizing 
subjects); 55.1% have had >4 non-substance-related manic episodes in their lifetime 
compared with 42.8% of non-externalizing subjects (and 53.5% of externalizing subjects). 
They have an earlier age of onset of bipolar disorder by more than 5 years (at 16.0 years 
compared to 20.4 years) and these ages are similar to the ages of first depressive episode; 
age of first mania is also advanced by more than 5 years (21.3 years compared to 26.6 
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years). Number of suicide attempts is greater (3.6 vs 2.6) and age of first attempt is >4 years 
earlier (20.3 years vs 24.5 years). Patterns are very similar in the Validation sample.
To determine whether the differences in the clinical parameters between subjects in the non-
externalizing and Externalizing Groups can be accounted for by substance use disorders, 
separate linear regression analyses were performed using frequency of clean depressive 
episodes/clean manic episodes as the dependent variable, and externalizing disorder status, 
presence of alcohol abuse/dependence, presence of drug abuse/dependence, ethnicity, 
presence/absence of first degree relatives with BPI and cohort (years of ascertainment) as 
independent variables controlling for age and gender in the Discovery sample. The 
frequency of depressive episodes was found to be a function of externalizing disorder status 
(standardized β=0.119, P=0.021), but was not completely explained by the presence of 
alcohol abuse/dependence (P>0.05) or drug abuse/dependence (P>0.05). The frequency of 
manic episodes was not found to be a function of externalizing disorder status (P>0.05), the 
presence of alcohol abuse/dependence (P>0.05) or the presence of drug abuse/dependence 
(P>0.05), but appeared to be related to cohort (P<0.05). This may be related to the 
preponderance of multiplex families in the earlier cohorts. We further examined the effect of 
externalizing disorder status controlling for alcohol abuse/dependence in one analysis and 
drug abuse/dependence in a separate analysis on age at onset of BPI, one of the clinical 
parameters observed to be significantly different between the non-externalizing and 
Externalizing Groups. A significant (P<0.05) effect of externalizing disorder status was still 
observed even when controlling for alcohol and drug use disorders in the two analyses (data 
not shown). This suggests that other externalizing disorders such as ASPD (Swann et al., 
2010), pathological gambling (Kim et al., 2006), ADHD and CD (Masi et al., 2008) may 
explain a substantial part of the differences seen in the clinical parameters between the 
externalizing and Non-Externalizing Groups.
3.4. Genetic association analyses
Two GWAS analyses were performed comparing: 1) 784 subjects in the Non-Externalizing 
Group vs. 1280 subjects in the Externalizing Group; 2) 784 subjects in the Non-
Externalizing Group vs. 502 subjects in the Early-Onset Subgroup. QC was performed on all 
subjects and all SNPs, as summarized above. Although no SNP reached genome-wide 
significance (P<5 × 10−8) from the two analyses, a number of SNPs were found to be 
associated at a P-value of 10−5 or lower. Details of 20 SNPs with the strongest association 
signals from each of the two analyses are shown in Table 5. Since gene variants associated 
with bipolar disorder have been reported to be enriched for calcium channel genes, we 
examined that pathway (Cross-Disorder Group of the Psychiatric Genomics, 2013; Sklar et 
al., 2011) but saw no evidence for enrichment of calcium channel genes in either analysis. 
We also performed GWAS analyses comparing each of the three groups with the control 
group, but did not identify any genome-wide significant SNPs in any of these comparisons 
(data not shown).
4. Discussion
The purpose of this study was to determine clinical and genetic differences between BPI 
subjects who had externalizing disorders and those who did not have externalizing disorders. 
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We found that a majority of Discovery and Validation sample BPI subjects had externalizing 
disorders. We believe that this is the largest cohort of BPI subjects (total N=2505) analyzed 
for factors associated with externalizing symptomatology. Two factors: internalizing and 
externalizing, appear to substantially account for psychiatric comorbidity among BPI 
subjects (Monahan et al., in press).
A significant difference in a majority of clinical parameters were found when we compared 
subjects in the non-externalizing and Externalizing Groups as well as subjects in the Non-
Externalizing Group and the Early-Onset Subgroup (Tables 3 and 4, online Tables S6 and 
S7). A possible explanation for the differences seen between these groups is the high 
proportion of subjects with alcohol abuse/dependence and/or drug abuse/dependence (Table 
2). However, our regression studies show that the differences in clinical parameters are not 
completely explained by the presence or absence of substance use disorders.
The most remarkable result of this study was the increased severity and frequency of mood 
disorder symptoms and episodes in the Externalizing Group and particularly in the early-
onset externalizing subgroup. In every parameter tested, subjects with externalizing 
disorders show evidence of greater symptomatology, earlier onset, and more impairment. 
This is true even when care is taken to exclude the direct effects of substances (e.g. the 
exclusion of substance-related depressive or manic episodes). In general the chronology 
suggests that substance use precedes episodes of major mood disorder but it is not clear 
whether minor mood problems may precede substance use or abuse. In any case, the 
divisions highlighted in this report appear to be clinically salient.
We noted a higher proportion of subjects in the Validation sample with ADHD compared to 
the Discovery sample. A section for adult ADHD was included in DIGS 4.0 used for later 
cohorts but the earlier versions had only a retrospective report of childhood ADHD. 
Inclusion of the adult ADHD section may be expected to have increased the frequency of 
ADHD reports (including retrospective childhood ADHD). It is not clear to us how to 
explain the decrease in ASPD diagnoses and drug abuse/dependence diagnoses in the 
Validation Sample compared to the Discovery sample. Site effects cannot be ruled out (as 
the four original sites contributed to a larger proportion of the Discovery sample in 
comparison to the Validation sample), and such effects have been demonstrated in other 
studies of bipolar subphenotypes (Saunders et al., 2008). However it is reassuring to note the 
similarity of the proportions of externalizing and early-onset subjects in the two samples, as 
well as the very similar results with respect to clinical variables (Tables 3 and 4, Tables S6 
and S7).
Although no SNP reached genome-wide significance (P<5 × 10−8) in the two GWAS 
analyses, a number of potential candidate SNPs were found to be nominally associated 
(P<10−5) (Table 5). Two intronic SNPs (rs9359856 and rs6934804) and one coding SNP 
(rs2273238) were identified in the ANKRD6 (ankyrin repeat domain 6) gene on chromosome 
6. Also known as Diversin, the gene has been shown to be an essential component of the 
Wnt-signaling pathway, controlling fusion of heart precursors and gastrulation movements 
in zebrafish embryogenesis (Moeller et al., 2006; Schwarz-Romond et al., 2002). It has been 
shown to be prominently expressed in the developing mouse brain suggesting a role during 
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brain development and variants in the gene have been associated with muscle performance 
and habitual physical activity (Tissir et al., 2002; Van Deveire et al., 2012). A SNP in a gene 
in the same family (ANKRD26) was also noted in this short list. Variants in other identified 
genes have been associated with fasting glucose-related traits (GLIS3, TMEM195 and 
ZMAT4) (Dupuis et al., 2010; Meigs et al., 2007) and Alzheimer’s disease (MTHFD1L) (Naj 
et al., 2010). Cerebral glucose metabolic rates are known to be altered in mood disorders 
(Baxter et al., 1985; Drevets et al., 1997). SNPs in or near ST6GALNAC3, associated with 
carbohydrate metabolism, are seen three times in this list of 40. Thus, a number of SNPs 
associated with other diseases/complex traits may play a role in predisposition to 
externalizing disorders in the presence of bipolar illness. There is no evidence of an 
enrichment of calcium channel genes, suggesting that this pathway is not likely to explain 
the difference between externalizing and non-externalizing subtypes of BPI disorder.
The present study includes 2505 unrelated BPI subjects in two samples with clinical and 
genetic data. Subjects from two different ethnic populations (EA and AA) were analyzed for 
clinical parameters. However, this is a modest sample size for GWAS analyses and possible 
significant associations are likely to have been missed. Validation at genome-wide 
significance levels would be needed to confirm the suggestive associations identified in the 
present study.
5. Conclusion
In sum, we have demonstrated that BPI subjects with externalizing disorders tend to have a 
poorer clinical outcome then those without externalizing disorders; this is particularly true of 
those subjects with early onset of conduct disorder symptoms. Although no SNP reached 
genome-wide significance in the GWAS analyses, it does seem important to us that calcium 
channel genes do not appear to explain the genetic variance between externalizing and Non-
Externalizing Groups of BPI subjects. The clinical results in particular suggest the presence 
of an externalizing disorder subphenotype within BPI warranting further investigation.
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